• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Distinct roles of SNARE-mimicking lipopeptides during initial steps of membrane fusion?
  Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Overview of Cyclohexanebutanoic acid, α-amino-, ethyl ester, hydrochloride (1:1), (αS)- (CAS No. 402474-20-8)

The compound Cyclohexanebutanoic acid, α-amino-, ethyl ester, hydrochloride (1:1), (αS)- (CAS No. 402474-20-8) is a chiral derivative of cyclohexanebutanoic acid, featuring an ethyl ester and an α-amino group in its structure. This hydrochloride salt form is widely utilized in pharmaceutical research and organic synthesis due to its stereospecificity and potential bioactivity. The (αS) configuration indicates its enantiomeric purity, making it valuable for asymmetric synthesis and drug development. Researchers often explore its role in modulating biological pathways or as a building block for complex molecules.

In recent years, the demand for enantiomerically pure compounds like Cyclohexanebutanoic acid, α-amino-, ethyl ester, hydrochloride (1:1), (αS)- has surged, driven by advancements in chiral drug design and green chemistry. Users frequently search for "chiral building blocks in drug discovery" or "stereoselective synthesis techniques," reflecting industry trends toward precision medicine. The compound’s ethyl ester moiety enhances solubility, a critical factor in formulation studies, while its hydrochloride salt form improves stability—key considerations for pharmaceutical applications.

The synthesis of CAS No. 402474-20-8 typically involves multi-step reactions, including esterification and resolution of enantiomers. Analytical techniques such as HPLC and NMR are employed to confirm its purity and stereochemistry. Notably, its structural features align with growing interest in "sustainable synthetic methods" and "biocompatible intermediates," topics dominating academic and industrial forums. Its potential as a precursor for bioactive molecules further elevates its relevance in medicinal chemistry.

From an SEO perspective, integrating keywords like "chiral compounds for pharmaceuticals" or "high-purity amino acid derivatives" can enhance visibility. The compound’s versatility also intersects with trending queries such as "role of enantiopure compounds in APIs" (Active Pharmaceutical Ingredients). As regulatory standards tighten, the importance of rigorously characterized compounds like Cyclohexanebutanoic acid, α-amino-, ethyl ester, hydrochloride (1:1), (αS)- will continue to rise, positioning it as a focal point in cutting-edge research.

In summary, CAS No. 402474-20-8 exemplifies the intersection of synthetic chemistry and pharmaceutical innovation. Its chiral integrity, functional groups, and salt form cater to diverse applications—from drug development to material science. By addressing user queries on "advanced synthetic intermediates" and "stereochemistry in drug design," this overview bridges scientific rigor with industry demands, ensuring both readability and technical depth.

• 2743-60-4((S)-Ethyl 2-amino-4-methylpentanoate)
• 1664-34-2(Ethyl 1-Aminocyclohexanecarboxylate)
• 394735-17-2(Ethyl 2-amino-3-cyclobutylpropanoate)
• 23032-21-5((R)-Methyl 2-amino-4-methylpentanoate)
• 16450-41-2(L-Glutamic acid,1,5-diethyl ester)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)